Survival benefit of neoadjuvant chemotherapy versus adjuvant chemotherapy in HER2-positive early breast cancer: A propensity score-weighted analysis

首页> 外文期刊>Intelligence: A Multidisciplinary Journal >Survival benefit of neoadjuvant chemotherapy versus adjuvant chemotherapy in HER2-positive early breast cancer: A propensity score-weighted analysis

【24h】

Survival benefit of neoadjuvant chemotherapy versus adjuvant chemotherapy in HER2-positive early breast cancer: A propensity score-weighted analysis

机译：Neoadjuvant化疗的生存效果与Her2阳性早期乳腺癌的佐剂化疗：倾向评分加权分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Intelligence: A Multidisciplinary Journal》 |2020年第2020期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心理学;
关键词

相似文献

外文文献
中文文献
专利

1. Survival benefit of neoadjuvant chemotherapy versus adjuvant chemotherapy in HER2-positive early breast cancer: A propensity score-weighted analysis [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：Neoadjuvant化疗的生存效果与Her2阳性早期乳腺癌的佐剂化疗：倾向评分加权分析
2. Interim overall survival analysis of APHINITY (BIG 4-11): A randomized multicenter, double-blind, placebo-controlled trial comparing chemotherapy plus trastuzumab plus pertuzumab versus chemotherapy plus trastuzumab plus placebo as adjuvant therapy in patients with operable HER2-positive early breast cancer [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：临时整体生存分析奥海蒂（BIG 4-11）：随机多中心，双盲，安慰剂对照试验比较化疗加上曲妥珠单抗Plusutuzumab与化疗加上Rrastuzumab加安慰剂作为可操作Her2阳性早期乳腺癌患者的辅助治疗
3. 5170 Breast cancer - Clinical early disease Neoadjuvant versus adjuvant chemotherapy for women with operable breast cancer: a matched-pair analysis and prognostic factors on overall survival [J] . A.Arnaud, G.Crehange, S.Dabakuyo, European Journal of Cancer Supplements . 2009,第2期

机译：5170乳腺癌-患有可手术性乳腺癌的妇女的新辅助化疗与辅助化疗的临床早期疾病：配对分析和总体生存率的预后因素
4. Deformable image registration as a tool to improve survival prediction after neoadjuvant chemotherapy for breast cancer: Results from the ACRIN 6657/I-SPY-1 trial [C] . Nariman Jahani, Eric Cohen, Meng-Kang Hsieh, SPIE Medical Imaging Conference . 2018

机译：可变形图像配准作为改善乳腺癌新辅助化疗后生存预测的工具：ACRIN 6657 / I-SPY-1试验的结果
5. The Effects of Adjuvant Chemotherapy on Brain Function in Breast Cancer Patients and a Cancer-Chemotherapy Rodent Model. [D] . Barr, Alicia Thomas. 2014

机译：辅助化疗对乳腺癌患者脑功能的影响和癌症化学疗法的啮齿动物模型。
6. Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancer [O] . Carlo Palmieri, Iain RJ Macpherson, Kelvin Yan, 2016

机译：HER2阳性乳腺癌患者新辅助化疗和曲妥珠单抗对比新辅助化疗加曲妥珠单抗术后
7. HER2-Positive Breast Cancer Patients with Pre-Treatment Axillary Involvement or Postmenopausal Status Benefit from Neoadjuvant Rather than Adjuvant Chemotherapy Plus Trastuzumab Regimens [O] . Enora Laas, Arnaud Bresset, Jean-Guillaume Féron, 2021

机译：Her2阳性乳腺癌患者预处理腋下受累或绝经后状态从Neoadjuvant而不是佐剂化疗加上曲妥珠单抗方案

Survival benefit of neoadjuvant chemotherapy versus adjuvant chemotherapy in HER2-positive early breast cancer: A propensity score-weighted analysis

著录项

相似文献

相关主题

期刊订阅